Ledipasvir/Sofosbuvir (LDV/SOF) fixed-dose combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ledipasvir/Sofosbuvir (LDV/SOF) fixed-dose combination, covering 2017-02-28 to 2017-02-28. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection [Phase 2]